Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Classement en actions #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Prix de l'action
$0.12164306
Dernière synchronisation: 2024-11-11
Capitalisation boursière
$38.53M
Changement (1 jour)
-4.14%
Changement (1 an)
0.00%
Pays
AU
Échange PharmAust Limited (PAA)

Catégorie

Le prix PAA avec la capitalisation boursière de B
PharmAust Limited PharmAust Limited
PAA
$0.12164306
Capitalisation boursière de PharmAust Limited(PAA)
Capitalisation boursière: $38.53M
En August 2026, PharmAust Limited a une capitalisation boursière de $38.53M. Cela fait de PharmAust Limited la 26700th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de PharmAust Limited du 2001 au 2026
PAA par rapport au top 5 des plus populaires stocks
Prix pour PAA L’actif B La capitalisation boursière de B Résultats
PharmAust Limited PharmAust Limited
$16,755.65 $38.53M
$5.307T +13,774,337.61%
PharmAust Limited PharmAust Limited
$14,831.00 $38.53M
$4.697T +12,192,126.35%
PharmAust Limited PharmAust Limited
$13,092.66 $38.53M
$4.147T +10,763,080.60%
PharmAust Limited PharmAust Limited
$11,331.86 $38.53M
$3.589T +9,315,566.27%
PharmAust Limited PharmAust Limited
$9,019.56 $38.53M
$2.857T +7,414,671.83%